Evidence map›Paper›PMID 41523628›Full record

ArticleJournal of clinical and translational science2025

Developing a genetic return of results service core.

Jennifer A McKenzie, Erin McRoy, Kevin M Bowling, Jorge Luis Granadillo De Luque, Jessica Mozersky, Erin Linnenbringer, Dustin Baldridge, Jonathan W Heusel, Julie A Neidich, Amanda F Cashen and 3 more

Abstract read
In one paragraph

Article in Journal of clinical and translational science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Jennifer A McKenzieWashington University Institute of Clinical and Translational Sciences, Washington University in St. Louis, St. Louis, MO, USA.ORCID https://orcid.org/0000-0002-5723-4057
Erin McRoyWashington University Institute of Clinical and Translational Sciences, Washington University in St. Louis, St. Louis, MO, USA.
Kevin M BowlingWashington University Institute of Clinical and Translational Sciences, Washington University in St. Louis, St. Louis, MO, USA.
Jorge Luis Granadillo De LuqueWashington University Institute of Clinical and Translational Sciences, Washington University in St. Louis, St. Louis, MO, USA.
Jessica MozerskyWashington University Institute of Clinical and Translational Sciences, Washington University in St. Louis, St. Louis, MO, USA.ORCID https://orcid.org/0000-0002-4942-4571
Erin LinnenbringerWashington University Institute of Clinical and Translational Sciences, Washington University in St. Louis, St. Louis, MO, USA.
Dustin BaldridgeWashington University Institute of Clinical and Translational Sciences, Washington University in St. Louis, St. Louis, MO, USA.
Jonathan W HeuselWashington University Institute of Clinical and Translational Sciences, Washington University in St. Louis, St. Louis, MO, USA.
Julie A NeidichWashington University Institute of Clinical and Translational Sciences, Washington University in St. Louis, St. Louis, MO, USA.
Amanda F CashenWashington University Institute of Clinical and Translational Sciences, Washington University in St. Louis, St. Louis, MO, USA.
Laura J BierutWashington University Institute of Clinical and Translational Sciences, Washington University in St. Louis, St. Louis, MO, USA.
Sarah M HartzWashington University Institute of Clinical and Translational Sciences, Washington University in St. Louis, St. Louis, MO, USA.
Christina A GurnettWashington University Institute of Clinical and Translational Sciences, Washington University in St. Louis, St. Louis, MO, USA.

Funding

WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
NCATS NIH HHS UL1 TR002345
6 · The paper itself

Abstract

Research participants should be informed of genetic test results that could impact their health, particularly when they have expressed interest in receiving such information. Furthermore, the return of genetic test results is essential to improve trust, transparency, and health equity. However, investigators often encounter barriers in returning genetic test results to research participants. We examined genomic research at a large, research-intensive medical school and found less than 6% of protocols included plans to return results to participants. This study describes our development of protocols for returning primary and secondary genetic test results and implementation of a Genomic Return of Results (gROR) service. This arose through a collaboration with experts in community engagement, genetics, and pathology to consider consent adequacy, analytical/clinical validity, and clinical utility when returning results. The gROR service reduces investigator burden and provides participants with genetic information and guidance to address any potential health risks. Genetic results are returned by a genetic counselor at no cost to participants or their family. Investigator costs are subsidized to incentivize the delivery of actionable genetic test results to research participants. Our approach prioritizes transparency, accessibility, and informed decision-making, thereby promoting equitable sharing of genetic knowledge and personalized healthcare interventions.

Indexed as

geneticsgenomicsresearch participantsReturn of resultsservice

Identifiers

PMID41523628
PMCPMC12779444

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.